Baxter Taps New Technologies, Forms Collaborations to Improve Environmental Sustainability and Access to HealthcareApril 2, 2013 9:00 am | by The Associated Press | News | Comments
DEERFIELD, Ill.--(BUSINESS WIRE)--Apr 2, 2013--Baxter International Inc. (NYSE: BAX) is incorporating innovative technologies and has recently established new partnerships in its commitment to environmental sustainability and increasing access to healthcare. Recently the company initiated...
A look at the most acquisitive medical device companies, culled from MassDevice.com's Big 100 database of more than 1,300 medical device industry transactions. More than $50 billion was spent on acquisitions by Big 100 medical device companies from the beginning of 2011 through the 1st half of 2012.
Baxter International's bets in emerging markets pay off during the 2nd quarter with growth in plasma sales. Baxter (NYSE:BAX) reported modest growth in sales and a healthy surge in profit during the 2nd quarter, which the company attributed partially to increasing demand for its plasma products in emerging markets.
Baxter Announces FDA Approval of Expanded Indication for TISSEEL [Fibrin Sealant] for General Hemostasis in SurgeryJanuary 31, 2012 5:53 am | News | Comments
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved TISSEEL [Fibrin Sealant] to include general hemostasis in surgery when control of bleeding by standard surgical techniques is ineffective or impractical.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. announced today that Jean-Luc Butel has been appointed corporate vice president and president, international, reporting to Robert L. Parkinson, Jr., chairman and chief executive officer. He will assume his new role on February 20, 2012.
Baxter Introduces NUMETA in Europe as the First-Ever Triple-Chamber IV Nutrition System for Preterm Newborns and ChildrenNovember 7, 2011 5:40 am | News | Comments
HANOVER, Germany--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) announced today the European launch of NUMETA (emulsion for infusion). NUMETA was introduced at the 22nd Annual European Society of Pediatric and Neonatal Intensive Care (ESPNIC) Medical...